Continuous Subcutaneous Glucose Monitoring in Critical Patients

This is a single-center, observational, descriptive, longitudinal, and prospective study This study aims to determine the cumulative incidence during admission and the incidence rate of potential hypoglycemic events (defined as subcutaneous glucose \<80 mg/dL detected by CGM) in patients admitted to the Intensive Care Unit (ICU) of HLA Moncloa Hospital over four years of follow-up. The study also aims to document the occurrences of hypoglycemic events, describe the characteristics of patients receiving CGM sensors, and outline the actions taken as a result of detecting potential hypoglycemic events

NCT Number	NCT06234787
Lead Sponsor	Universidad Europea de Madrid
Conditions	Hyperglycemia, Hypoglycemia, Diabetes, Critical Care, Critically Ill Patients
Enrollment	245 participants
Start Date	2023-11-30
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2024-02-05